NEW YORK (GenomeWeb News) — Roche Diagnostics will work with the Foundation for Innovative New Diagnostics to study the potential uses of in vitro diagnostics for “poverty related” diseases, the groups said today.
Under the plan, FIND, a Swiss non-profit that promotes health in developing countries, will conduct product evaluation studies with Roche’s help. These programs will attempt to adapt IVD technology to the needs of underprivileged populations, especially those at risk for tuberculosis, sleeping sickness, and malaria.
FIND CEO Giorgio Roscigno said the group is “hopeful that IVD tools that are efficient, user-friendly, and affordable can significantly increase the quality of diagnosis in these regions.”
FIND is funded by the Bill & Melinda Gates Foundation, the US Agency for International Development, the European Union and the Dutch Government.